Annals of Oncology 13:1786-1791, 2002
© 2002 European Society for Medical Oncology
Original Paper |
Long-term risk of second malignancy after treatment of Hodgkin’s disease: the influence of treatment, age and follow-up time
1 Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Oslo; 2 The Cancer Registry of Norway, Oslo, Norway
Received 15 January 2002; revised 2 May 2002; accepted 22 May 2002
Background:
To quantify the long-term risk of second cancers (SCs) up to 30 years after primary treatment for Hodgkin’s disease (HD)
Material and methods
In the period 1968 to 1985, an unselected population of 1024 patients started treatment for HD at the Norwegian Radium Hospital (NRH) and were followed for SC from 1969 through 1998 by The Norwegian Cancer Registry. The median age at diagnosis of HD was 40 years, and the median time at follow-up was 14 years.
Results:
Of 197 SCs, 14 were acute non-lymphocytic leukemia (ANLL), 31 non-Hodgkin’s lymphoma (NHL) and 152 solid cancers. The standardized incidence ratio (SIR) was significantly increased for SCs as a group, and for the subgroups ANLL, NHL, lung cancer, breast cancer, stomach cancer and melanoma. ANLL was related to heavy treatment with chemotherapy (CT) and combined CT and radiotherapy (RT), NHL was not treatment related, and solid tumors were related to radiotherapy only or combined RT and CT. The SIR of ANLL and NHL reached a peak between 5 and 10 years after treatment. Solid and non-solid tumors increased with young age at diagnosis of HD and solid tumors increased with follow-up time up to 28 years
Conclusion:
In a long-term follow-up study of HD patients of all ages, the SIR of solid tumors was high in patients treated at young age and decreased with increasing age. Most solid tumors had started within or at the edge of the irradiated field, and SIR of solid tumors increased even 20–30 years after diagnosis.
Key words: Hodgkin’s disease, second malignancies
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Furth, I. G. Steffen, H. Amthauer, J. Ruf, D. Misch, S. Schonberger, C. Kobe, T. Denecke, B. Stover, H. Hautzel, et al. Early and Late Therapy Response Assessment With [18F]Fluorodeoxyglucose Positron Emission Tomography in Pediatric Hodgkin's Lymphoma: Analysis of a Prospective Multicenter Trial J. Clin. Oncol., September 10, 2009; 27(26): 4385 - 4391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Metzger, S. M. Castellino, M. M. Hudson, S. N. Rai, S. C. Kaste, M. J. Krasin, L. E. Kun, C.-H. Pui, and S. C. Howard Effect of Race on the Outcome of Pediatric Patients With Hodgkin's Lymphoma J. Clin. Oncol., March 10, 2008; 26(8): 1282 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Hodgson, E. S. Gilbert, G. M. Dores, S. J. Schonfeld, C. F. Lynch, H. Storm, P. Hall, F. Langmark, E. Pukkala, M. Andersson, et al. Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma J. Clin. Oncol., April 20, 2007; 25(12): 1489 - 1497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Krishnan and G. J. Morgan Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 377 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Das, A. K. Ng, C. C. Earle, P. M. Mauch, and K. M. Kuntz Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis Ann. Onc., May 1, 2006; 17(5): 785 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Schonfeld, E. S. Gilbert, G. M. Dores, C. F. Lynch, D. C. Hodgson, P. Hall, H. Storm, A. Andersen, E. Pukkala, E. Holowaty, et al. Acute Myeloid Leukemia Following Hodgkin Lymphoma: A Population-Based Study of 35 511 Patients J Natl Cancer Inst, February 1, 2006; 98(3): 215 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Das, A. K. Ng, M. A. Stevenson, and P. M. Mauch Clinical course of thoracic cancers in Hodgkin's disease survivors Ann. Onc., May 1, 2005; 16(5): 793 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Behringer, A. Josting, P. Schiller, H. T. Eich, H. Bredenfeld, V. Diehl, and A. Engert Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group Ann. Onc., July 1, 2004; 15(7): 1079 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Schwarz and R. K. Strair Complications of Malignancy: CASE 2. Infectious Tissue Pneumatosis As a Result of Colon Cancer Perforation in a Survivor of Hodgkin's Disease J. Clin. Oncol., January 15, 2004; 22(2): 373 - 374. [Full Text] [PDF]
|
|